KYMR
Price
$66.23
Change
+$0.24 (+0.36%)
Updated
Dec 4, 04:59 PM (EDT)
Capitalization
4.75B
77 days until earnings call
Intraday BUY SELL Signals
TBPH
Price
$18.70
Change
-$0.19 (-1.01%)
Updated
Dec 4, 04:59 PM (EDT)
Capitalization
957.2M
88 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

KYMR vs TBPH

Header iconKYMR vs TBPH Comparison
Open Charts KYMR vs TBPHBanner chart's image
Kymera Therapeutics
Price$66.23
Change+$0.24 (+0.36%)
Volume$9.85K
Capitalization4.75B
Theravance Biopharma
Price$18.70
Change-$0.19 (-1.01%)
Volume$6.02K
Capitalization957.2M
KYMR vs TBPH Comparison Chart in %
View a ticker or compare two or three
VS
KYMR vs. TBPH commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a Hold and TBPH is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 05, 2025
Stock price -- (KYMR: $65.99 vs. TBPH: $18.89)
Brand notoriety: KYMR and TBPH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 73% vs. TBPH: 120%
Market capitalization -- KYMR: $4.75B vs. TBPH: $957.2M
KYMR [@Biotechnology] is valued at $4.75B. TBPH’s [@Biotechnology] market capitalization is $957.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whileTBPH’s FA Score has 0 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • TBPH’s FA Score: 0 green, 5 red.
According to our system of comparison, both KYMR and TBPH are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 3 TA indicator(s) are bullish while TBPH’s TA Score has 3 bullish TA indicator(s).

  • KYMR’s TA Score: 3 bullish, 3 bearish.
  • TBPH’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, KYMR is a better buy in the short-term than TBPH.

Price Growth

KYMR (@Biotechnology) experienced а -2.76% price change this week, while TBPH (@Biotechnology) price change was -5.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.21%. For the same industry, the average monthly price growth was +5.86%, and the average quarterly price growth was +56.03%.

Reported Earning Dates

KYMR is expected to report earnings on Feb 19, 2026.

TBPH is expected to report earnings on Mar 02, 2026.

Industries' Descriptions

@Biotechnology (+1.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($4.75B) has a higher market cap than TBPH($957M). TBPH YTD gains are higher at: 100.744 vs. KYMR (64.032). TBPH has higher annual earnings (EBITDA): 46.1M vs. KYMR (-267.03M). KYMR has more cash in the bank: 665M vs. TBPH (339M). TBPH has less debt than KYMR: TBPH (46.5M) vs KYMR (85.7M). TBPH has higher revenues than KYMR: TBPH (77.2M) vs KYMR (44.7M).
KYMRTBPHKYMR / TBPH
Capitalization4.75B957M496%
EBITDA-267.03M46.1M-579%
Gain YTD64.032100.74464%
P/E RatioN/A33.14-
Revenue44.7M77.2M58%
Total Cash665M339M196%
Total Debt85.7M46.5M184%
FUNDAMENTALS RATINGS
TBPH: Fundamental Ratings
TBPH
OUTLOOK RATING
1..100
31
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
80
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
86
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KYMRTBPH
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
76%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
66%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
65%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 7 days ago
84%
Bullish Trend 7 days ago
79%
Declines
ODDS (%)
N/A
Bearish Trend 28 days ago
70%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
67%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
KYMR
Daily Signal:
Gain/Loss:
TBPH
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PPVIX12.530.21
+1.70%
Principal SmallCap Value II Instl
TGVNX31.280.50
+1.62%
TCW Relative Value Mid Cap N
GPGIX3.650.04
+1.11%
Grandeur Peak Global Opportunities Instl
GSPAX19.180.07
+0.37%
Goldman Sachs US Eq Div and Premium A
TRAIX38.930.05
+0.13%
T. Rowe Price Capital Appreciation I

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with NRIX. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
+2.68%
NRIX - KYMR
62%
Loosely correlated
+2.94%
VERA - KYMR
59%
Loosely correlated
+10.77%
KURA - KYMR
55%
Loosely correlated
+7.55%
CGON - KYMR
53%
Loosely correlated
+3.00%
IDYA - KYMR
52%
Loosely correlated
+1.93%
More

TBPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, TBPH has been loosely correlated with KYMR. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if TBPH jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TBPH
1D Price
Change %
TBPH100%
+2.50%
KYMR - TBPH
46%
Loosely correlated
+2.68%
VYGR - TBPH
38%
Loosely correlated
+12.20%
LYRA - TBPH
36%
Loosely correlated
+4.49%
VERA - TBPH
36%
Loosely correlated
+10.77%
RGNX - TBPH
35%
Loosely correlated
+5.49%
More